COVID-19 Impacts 565 Pharma-Bio Industry Projects, an Industrial Info Market Brief

Despite its status as an essential industry, the Pharmaceuticals & Biotech Industry has not escaped the effects of the COVID-19 pandemic. Across the globe, 565 reported projects representing more than $12 billion have been delayed or put on indefinite hold. Stay-at-home orders appear to be the number one cause, as companies scrambled to comply and secure the safety of essential workers inside of operational plants.

Most of the projects are expected to be revived as better understanding and guidelines for COVID-19 are developed.